This free case-based activity includes a crowd-sourced discussion of a 55-year-old woman with a history of infiltrating mixed ductal/lobular carcinoma. Originally posted on a forum in the ASCO Connection, users now have the opportunity to claim CME, completion, or participation certificates for completing this activity.
- Analyze treatment options for patients with ER+ metastatic breast cancer
- Apply molecular testing options in patients with ER+ metastatic breast cancer
- Evaluate the role of PIK3CA mutation in mediating resistance to endocrine therapy
- Discuss the pathologist’s role in biomarker testing and molecular testing for metastatic breast cancer
This activity was made available on 3/26/2015 and will be reviewed on an annual basis to determine continued availability. A maximum of 1 AMA PRA Category 1 Credit ™ is available.
Medical Knowledge (ACGME, AAPA)
Health Promotion, Health Protection, Disease Prevention, and Treatment (ONS)